Cargando…

Analysis of Pharmacogenomic Variants Associated with Population Differentiation

In the present study, we systematically investigated population differentiation of drug-related (DR) genes in order to identify common genetic features underlying population-specific responses to drugs. To do so, we used the International HapMap project release 27 Data and Pharmacogenomics Knowledge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeon, Bora, Ahn, Eunyong, Kim, Kyung-Im, Kim, In-Wha, Oh, Jung Mi, Park, Taesung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373713/ https://www.ncbi.nlm.nih.gov/pubmed/25807276 http://dx.doi.org/10.1371/journal.pone.0119994

Ejemplares similares

Analysis of population-specific pharmacogenomic variants using next-generation sequencing data
por: Ahn, Eunyong, et al.
Publicado: (2017)

Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population
por: He, Chunjuan, et al.
Publicado: (2021)

Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population
por: Cheng, Yujing, et al.
Publicado: (2021)

Do we need to reconsider the CMAM admission and discharge criteria?; an analysis of CMAM data in South Sudan
por: Ahn, Eunyong, et al.
Publicado: (2020)

Joint Identification of Genetic Variants for Physical Activity in Korean Population
por: Kim, Jayoun, et al.
Publicado: (2014)

The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population
por: Khan, Abdul Rafay, et al.
Publicado: (2022)

Comprehensive pharmacogenomic characterization of gastric cancer
por: Sa, Jason K., et al.
Publicado: (2020)

Genetic Differentiation among Populations and Color Variants of Sea Cucumbers (Stichopus Japonicus) from Korea and China
por: Kang, Jung-Ha, et al.
Publicado: (2011)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021)

Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients
por: Jeong, Sohyun, et al.
Publicado: (2017)

Flat Pattern Peaks of Tacrolimus Absorption and Associated Pharmacogenomic Variants in Kidney Transplantation Recipients
por: Kim, Suh Min, et al.
Publicado: (2022)

Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics
por: Pandi, Maria-Theodora, et al.
Publicado: (2020)

Meta-Qtest: meta-analysis of quadratic test for rare variants
por: Ka, Jieun, et al.
Publicado: (2019)

Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China
por: Zhang, Chan, et al.
Publicado: (2019)

Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China
por: Li, Dandan, et al.
Publicado: (2021)

Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm)
por: Runcharoen, Chakkaphan, et al.
Publicado: (2021)

Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China
por: Wang, Li, et al.
Publicado: (2015)

Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province
por: Cheng, Yujing, et al.
Publicado: (2020)

Editorial: Pharmacogenomics in neglected populations
por: Botton, Mariana R., et al.
Publicado: (2022)

Population Pharmacogenomics for Health Equity
por: Jordan, I. King, et al.
Publicado: (2023)

Pathway analysis of rare variants for the clustered phenotypes by using hierarchical structured components analysis
por: Lee, Sungyoung, et al.
Publicado: (2019)

In silico comparative characterization of pharmacogenomic missense variants
por: Li, Biao, et al.
Publicado: (2014)

New Common and Rare Variants Influencing Metabolic Syndrome and Its Individual Components in a Korean Population
por: Lee, Ho-Sun, et al.
Publicado: (2018)

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
por: Sa, Jason K., et al.
Publicado: (2019)

Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province
por: Zhang, Chan, et al.
Publicado: (2018)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

Common Treatment, Common Variant: Evolutionary Prediction of Functional Pharmacogenomic Variants
por: Scheinfeldt, Laura B., et al.
Publicado: (2021)

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer
por: Ansari, Adnan Ahmad, et al.
Publicado: (2018)

The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023)

Genome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL/6J mice fed a high-fat diet
por: Kim, Sung-Eun, et al.
Publicado: (2017)

Family-based association analysis: a fast and efficient method of multivariate association analysis with multiple variants
por: Won, Sungho, et al.
Publicado: (2015)

Genetic polymorphisms of pharmacogenomic VIP variants in the Lisu population of southwestern China: A cohort study
por: Li, Bin, et al.
Publicado: (2018)

A Model-Based Joint Identification of Differentially Expressed Genes and Phenotype-Associated Genes
por: Cho, Samuel Sunghwan, et al.
Publicado: (2016)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomic analysis indicates potential of 1,5-isoquinolinediol as a universal anti-aging agent for different tissues
por: Park, Mi Sung, et al.
Publicado: (2015)

Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008)

Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China
por: Jin, Tianbo, et al.
Publicado: (2016)

Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
por: Schuh, Michael J., et al.
Publicado: (2020)

Genomewide Association Studies in Pharmacogenomics
por: McInnes, Gregory, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h59shk7ivt37d8gf5224k619er